"April 9, 2012 -- Drugs that treat incontinence caused by an overactive bladder offer modest benefits to some women, and they often come with significant side effects, a new review of research shows.
The government-funded review compar"...
- Patient Information:
Details with Side Effects
OXYTROL is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
DOSAGE AND ADMINISTRATION
OXYTROL 3.9 mg/day should be applied to dry, intact skin on the abdomen, hip, or buttock twice weekly (every 3 or 4 days). A new application site should be selected with each new system to avoid re-application to the same site within 7 days.
Dosage Forms And Strengths
Transdermal System: 3.9 mg/day
Storage And Handling
Unit Dose: Heat sealed pouch containing 1 OXYTROL (oxybutynin transdermal system).
Each 39 cm² system imprinted with “OXYTROL 3.9 mg/day” contains 36 mg of oxybutynin for nominal delivery of 3.9 mg oxybutynin per day when dosed in a twice weekly regimen.
NDC 52544-920-08 Patient Calendar Box of 8 Systems
Store at 20-25°C (68-77°F). [See USP controlled room temperature.] Protect from moisture and humidity. Do not store outside the sealed pouch. Apply immediately after removal from the protective pouch. Discard used OXYTROL in household trash in a manner that prevents accidental application or ingestion by children, pets, or others.
Keep out of reach of children.
For all medical inquiries contact: WATSON Medical Communications Parsippany, NJ 07054 800-272-5525. Distributed By: Watson Pharma, Inc. Parsippany, NJ 07054 USA. Revised: 10/2012
Last reviewed on RxList: 10/18/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Oxytrol Information
Oxytrol - User Reviews
Oxytrol User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.